Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma

Metabolic Profiling to Assess Response to Targeted and Immune Therapy in Melanoma

There is currently no consensus to determine which advanced melanoma patients will benefit from targeted therapy, immunotherapy, or a combination of both, highlighting the critical need to identify early-response biomarkers to advanced melanoma therapy. The goal of this review is to provide scientif...

Full description

Bibliographic Details
Main Authors: Chantale Farah, Lionel Mignion, Bénédicte F. Jordan
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
melanoma
metabolic imaging
response to treatment
BRAF-targeted therapy
immune checkpoint inhibitors
Online Access:https://www.mdpi.com/1422-0067/25/3/1725

Internet

https://www.mdpi.com/1422-0067/25/3/1725

Similar Items